A Brief Overview of Non-Alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma

 web solution
  13th-Feb-2019
 31

Non-Alcoholic Steatohepatitis (NASH)

Non-alcoholic Steatohepatitis is an advanced form of non-alcoholic fatty liver disease, which is usually caused by a buildup of fats in the liver, inflammation and damage cued by this buildup leads to NASH, which can end up scarring the liver. This liver scarring is a potentially life-threatening issue known as cirrhosis.

NASH is actually very synonymous to people who are obese or overweight. Its major causes include diabetes, high cholesterol, a poor diet, sleep apnea, metabolic syndrome, underactive thyroid, and much more

Hepatocellular Carcinoma(HCC)

Hepatocellular carcinoma is a cancer that begins from the liver. If caught early, the cancer can be easily cured with surgery or a transplant. However, more advanced cases can’t be cured, although the management of the disease is possible with proper treatment and support.

It’s also important that you get proper professionals- like Aligos Therapeutics- to help you with treating this disease

Here are a few causes of the disease:

Chronic hepatitis B or hepatitis C: Hepatocellular cancer can start a long time after a liver infection. Both are passed through infected body fluids like water and blood.

Cirrhosis: This happens when a liver cell is damaged and replaced. It can also be caused by various factors, such as too much iron in the liver, alcohol, and much more.

Heavy drinking: Constant and heavy drinking raises the risk of hepatocellular cancer. The more you drink, the more the risk.

For More Information Visit : https://www.aligos.com/

Domain: Business
Category: Companies
Posted By: web solution and Contact web solution
SEMICONDUCTOR ANALYTICS

Recent Press Releases

Ulcerative Colitis Market Growth, Co...

Global Ulcerative Colitis Market is expected to rise gradually to an estimated value of USD 10.51 billion by 2026, registering a CAGR of 5.4% in the forecast period of 2019-2026. T

16 September, 2019

Flavoured Yogurt Market Share, Growt...

Global flavoured yogurt market is projected to rise to USD 144.31 billion by 2026, undergoing growth with a healthy CAGR in the forecast period of 2019-2026. The rise in the market

16 September, 2019

Bio-pharmaceutical logistics Market ...

BlueWeave Consulting review study of Bio-pharmaceutical logistics Market anticipated to reach USD Million with a significant CAGR of 6.7% in the forecast period of 2015-25. Global

16 September, 2019